MUC1 and cancer: Additional emerging biomarkers in pancreatic cancer include Plectin-1, Mucin-1, and ZIP4, which are being explored for targeted imaging and therapeutic interventions, reflecting the growing sophistication of eco-AgNP applications in highly specific cancer types [70].